Prof. C.J.M. (Karin) Klijn, MD PhD
Karin Klijn studied medicine at Utrecht University. In 1993 she started her training in Neurology in Utrecht. She combined her training with research, resulting in her PhD thesis ‘Symptomatic Carotid Artery Occlusion; the haemodynamic perspective’ for which she was awarded cum laude (2001).
Since 2004 she was neurologist at the Brain Center Rudolf Magnus, Stroke Center, UMC Utrecht, combining clinical work and teaching with research. In June 2015 she was appointed professor and head of Neurology at the Radboud University Medical Center, Nijmegen, The Netherlands.
H. Bart van der Worp, MD PhD
Bart van der Worp studied medicine at Utrecht University and obtained his medical degree in 1991. He defended his PhD thesis "Treatment of acute ischaemic stroke with antioxidants. The gap between laboratory and clinic" in 1999. In 2000 he was registered as a neurologist.
Floris H.B.M. Schreuder, MD
Floris Schreuder studied medicine at Maastricht University where he graduated in 2007. Between 2009 and 2016, he combined his Neurology residency with research at the Department of Neurology of the Maastricht University Medical Center. Between July 2016 and July 2019, he worked as a research fellow at Department of Neurology of the Radboud University Medical Center.
Since July 2019, he works as vascular neurologist at the Department of Neurology of the Radboud University Medical Center.
Koen M. van Nieuwenhuizen, MD
Koen van Nieuwenhuizen studied medicine at Radboud University Nijmegen. He graduated with honors in 2013. After completing his research internship at the UMC Utrecht Department of Neurology & Neurosurgery (supervisor: Prof. Klijn), he commenced his PhD research in January 2014. Since July 2015, he started his Neurology residency in the UMC Utrecht.
Berber Zweedijk
Berber Zweedijk studied nursing in Utrecht and graduated in 2012.
Since 2013 she works as a research nurse in UMC Utrecht at the Department of Neurology and Neurosurgery, division Cerebral Vascular Diseases.
She is involved in a number of trials, of which most are investigator-initiated.
